Poultry Vaccines Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023
Global Poultry Vaccines Market: By Vaccine Type (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), By Formulation (Dry Form (Duct) Vaccines, Liquid Vaccines, Freeze Dried Vaccines), By Application (Marek’s Disease, Newcastle Disease, Infectious Bursal Disease, Infectious Bronchitis, Others), and Geography – Poultry Vaccines Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023
Market Dynamics: Poultry Vaccines Market
Vaccines are biological preparations that provide acquired immunity to particular disease in human beings or animals. Poultry vaccines are used to prevent or cure the various diseases in poultry such as Marek’s disease, Newcastle disease, and infectious diseases among others. Increase in the demand for healthy meat, rise in number of poultry industries, grow in R&D for the innovation of newer vaccines, and rise in prevalence of various infectious diseases are anticipated to fuel poultry vaccines market over the forecast period. Furthermore, government initiations for protecting the animal health, rise in veterinary healthcare expenditure, and vaccination programs organized by the companies are expected to boost the poultry vaccines market over the forecast period. However, stringent regulatory guidelines for the vaccine approval, adverse effects associated with vaccines, high R&D expenditure, and increase in adoption of vegetarian food may restrain the growth of poultry vaccines market over the forecast timeframe.
Market Scope: Poultry Vaccines Market
This market is segmented on the basis of vaccine type, formulation, application, and region
Based on the vaccine type, the market is segmented into the following:
Inactivated Vaccines
Live Attenuated Vaccines
Recombinant Vaccines
Based on the formulation, the market is segmented into the following:
Dry Form (Duct) Vaccines
Liquid Vaccines
Freeze Dried Vaccines
Based on the application, the market is segmented into the following:
Marek’s Disease
Newcastle Disease
Infectious Bursal Disease
Infectious Bronchitis
Others
Based on the region, the market is segmented into the following:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Regional Analysis: Poultry Vaccines Market
Geographically, global poultry vaccines market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America poultry vaccines market has a significant share owing to rise in demand for healthy meat, increase in R&D for the innovation of newer vaccines, and rise in veterinary healthcare expenditure. Europe poultry vaccines market is growing due to launching of newer vaccines into market, rise in prevalence of poultry diseases, and grow in per capita income. Asia Pacific poultry vaccines market expected to exhibit significant growth rate over the forecast period owing to increase in poultry production, government vaccination programs, and rise in population demand for healthy meat in China and India. Latin America poultry vaccines market growing due to adoption of newer vaccines, economic growth, and increase in consumption of poultry meat are propel the market. Middle East and Africa poultry vaccines market is driven by expansion of business by companies, rise in prevalence of zoonotic diseases, and increase in awareness about the vaccines expected to upsurge the revenue of market.
Competition Assessment: Poultry Vaccines Market
Key player profiles in the global poultry vaccines market include:
Zoetis (Pfizer, Inc.) (U.S.)
Merck & Co. Inc. (U.S)
Boehringer Ingelheim Vetmedica (Germany)
Elanco (U.S.)
Bayer Animal Health (Germany)
Ceva Sante Animale (France)
Indovax Pvt. Ltd. (India)
Hester Biosciences Limited. (India)
Zydus AHL (India)
Notable Market Developments: Poultry Vaccines Market
In November 2017, French firm Ceva Sante Animale launched two new poultry vaccines in India through joint venture with Ceva Polchem for the treatment of Gumboro disease and Ranikhet disease.
Key Features of the Report:
The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments and startup’s details that are actively working in the market
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Market Dynamics: Poultry Vaccines Market
Vaccines are biological preparations that provide acquired immunity to particular disease in human beings or animals. Poultry vaccines are used to prevent or cure the various diseases in poultry such as Marek’s disease, Newcastle disease, and infectious diseases among others. Increase in the demand for healthy meat, rise in number of poultry industries, grow in R&D for the innovation of newer vaccines, and rise in prevalence of various infectious diseases are anticipated to fuel poultry vaccines market over the forecast period. Furthermore, government initiations for protecting the animal health, rise in veterinary healthcare expenditure, and vaccination programs organized by the companies are expected to boost the poultry vaccines market over the forecast period. However, stringent regulatory guidelines for the vaccine approval, adverse effects associated with vaccines, high R&D expenditure, and increase in adoption of vegetarian food may restrain the growth of poultry vaccines market over the forecast timeframe.
Market Scope: Poultry Vaccines Market
This market is segmented on the basis of vaccine type, formulation, application, and region
Based on the vaccine type, the market is segmented into the following:
Inactivated Vaccines
Live Attenuated Vaccines
Recombinant Vaccines
Based on the formulation, the market is segmented into the following:
Dry Form (Duct) Vaccines
Liquid Vaccines
Freeze Dried Vaccines
Based on the application, the market is segmented into the following:
Marek’s Disease
Newcastle Disease
Infectious Bursal Disease
Infectious Bronchitis
Others
Based on the region, the market is segmented into the following:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Regional Analysis: Poultry Vaccines Market
Geographically, global poultry vaccines market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America poultry vaccines market has a significant share owing to rise in demand for healthy meat, increase in R&D for the innovation of newer vaccines, and rise in veterinary healthcare expenditure. Europe poultry vaccines market is growing due to launching of newer vaccines into market, rise in prevalence of poultry diseases, and grow in per capita income. Asia Pacific poultry vaccines market expected to exhibit significant growth rate over the forecast period owing to increase in poultry production, government vaccination programs, and rise in population demand for healthy meat in China and India. Latin America poultry vaccines market growing due to adoption of newer vaccines, economic growth, and increase in consumption of poultry meat are propel the market. Middle East and Africa poultry vaccines market is driven by expansion of business by companies, rise in prevalence of zoonotic diseases, and increase in awareness about the vaccines expected to upsurge the revenue of market.
Competition Assessment: Poultry Vaccines Market
Key player profiles in the global poultry vaccines market include:
Zoetis (Pfizer, Inc.) (U.S.)
Merck & Co. Inc. (U.S)
Boehringer Ingelheim Vetmedica (Germany)
Elanco (U.S.)
Bayer Animal Health (Germany)
Ceva Sante Animale (France)
Indovax Pvt. Ltd. (India)
Hester Biosciences Limited. (India)
Zydus AHL (India)
Notable Market Developments: Poultry Vaccines Market
In November 2017, French firm Ceva Sante Animale launched two new poultry vaccines in India through joint venture with Ceva Polchem for the treatment of Gumboro disease and Ranikhet disease.
Key Features of the Report:
The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments and startup’s details that are actively working in the market
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
1. EXECUTIVE SUMMARY
2. GLOBAL POULTRY VACCINES MARKET INTRODUCTION
2.1. Global Poultry Vaccines Market – Taxonomy
2.2. Global Poultry Vaccines Market –Definitions
2.2.1. Vaccine Type
2.2.2. Application
3. GLOBAL POULTRY VACCINES MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Poultry Vaccines Market Dynamic Factors - Impact Analysis
3.6. Global Poultry Vaccines Market – Regulations
3.6.1. U.S.
3.6.2. Europe
4. GLOBAL POULTRY VACCINES MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. GLOBAL POULTRY VACCINES MARKET ANALYSIS, BY VACCINE TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
5.1. Inactivated Vaccines
5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Live Attenuated Vaccines
5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Recombinant Vaccines
5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. GLOBAL POULTRY VACCINES MARKET ANALYSIS, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 – 2023
6.1. Marek’s Disease
6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Newcastle Disease
6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Infectious Bursal Disease
6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Infectious Bronchitis
6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. GLOBAL POULTRY VACCINES MARKET ANALYSIS, BY FORMULATION, 2012 - 2016 AND FORECAST, 2017 – 2023
7.1. Dry Form (Duct) Vaccines
7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Liquid Vaccines
7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Freeze Dried Vaccines
7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. GLOBAL POULTRY VACCINES MARKET ANALYSIS, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
8.1. North America
8.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Region, 2017 – 2023
9. NORTH AMERICA POULTRY VACCINES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
9.1. Vaccine Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Inactivated Vaccines
9.1.2. Live Attenuated Vaccines
9.1.3. Recombinant Vaccines
9.2. Application Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Marek’s Disease
9.2.2. Newcastle Disease
9.2.3. Infectious Bursal Disease
9.2.4. Infectious Bronchitis
9.2.5. Others
9.3. Formulation Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Dry Form (Duct) Vaccines
9.3.2. Liquid Vaccines
9.3.3. Freeze Dried Vaccines
9.4. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2017 – 2023
9.6. North America Poultry Vaccines Market Dynamics – Trends
10. EUROPE POULTRY VACCINES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
10.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.1.1. Germany
10.1.2. UK
10.1.3. France
10.1.4. Spain
10.1.5. Italy
10.1.6. Russia
10.1.7. Poland
10.1.8. Rest of Europe
10.2. Europe Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2017 – 2023
10.3. Europe Poultry Vaccines Market Dynamics – Trends
11. ASIA-PACIFIC POULTRY VACCINES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
11.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.1.1. Japan
11.1.2. China
11.1.3. India
11.1.4. ASEAN
11.1.5. Australia & New Zealand
11.1.6. Rest of Asia-Pacific
11.2. Asia-Pacific Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2017 – 2023
11.3. Asia-Pacific Poultry Vaccines Market Dynamics – Trends
12. LATIN AMERICA POULTRY VACCINES MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
12.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.1.1. Brazil
12.1.2. Mexico
12.1.3. Argentina
12.1.4. Venezuela
12.1.5. Rest of Latin America
12.2. Latin America Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2017 – 2023
12.3. Latin America Poultry Vaccines Market Dynamics – Trends
13. MIDDLE EAST AND AFRICA POULTRY VACCINES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
13.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.1.1. Gulf Cooperation Council (GCC) Countries
13.1.2. Israel
13.1.3. South Africa
13.1.4. Rest of MEA
13.2. MEA Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2017 – 2023
13.3. MEA Poultry Vaccines Market Dynamics – Trends
14. COMPETITION LANDSCAPE
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Zoetis (Pfizer, Inc.) (U.S.)
14.2.2. Merck & Co. Inc. (U.S)
14.2.3. Boehringer Ingelheim Vetmedica (Germany)
14.2.4. Elanco (U.S.)
14.2.5. Bayer Animal Health (Germany)
14.2.6. Ceva Sante Animale (France)
14.2.7. Indovax Pvt. Ltd. (India)
14.2.8. Hester Biosciences Limited. (India)
14.2.9. Zydus AHL (India)
15. RESEARCH METHODOLOGY
16. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL POULTRY VACCINES MARKET INTRODUCTION
2.1. Global Poultry Vaccines Market – Taxonomy
2.2. Global Poultry Vaccines Market –Definitions
2.2.1. Vaccine Type
2.2.2. Application
3. GLOBAL POULTRY VACCINES MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Poultry Vaccines Market Dynamic Factors - Impact Analysis
3.6. Global Poultry Vaccines Market – Regulations
3.6.1. U.S.
3.6.2. Europe
4. GLOBAL POULTRY VACCINES MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. GLOBAL POULTRY VACCINES MARKET ANALYSIS, BY VACCINE TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
5.1. Inactivated Vaccines
5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Live Attenuated Vaccines
5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Recombinant Vaccines
5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. GLOBAL POULTRY VACCINES MARKET ANALYSIS, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 – 2023
6.1. Marek’s Disease
6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Newcastle Disease
6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Infectious Bursal Disease
6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Infectious Bronchitis
6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. GLOBAL POULTRY VACCINES MARKET ANALYSIS, BY FORMULATION, 2012 - 2016 AND FORECAST, 2017 – 2023
7.1. Dry Form (Duct) Vaccines
7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Liquid Vaccines
7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Freeze Dried Vaccines
7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. GLOBAL POULTRY VACCINES MARKET ANALYSIS, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
8.1. North America
8.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Region, 2017 – 2023
9. NORTH AMERICA POULTRY VACCINES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
9.1. Vaccine Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Inactivated Vaccines
9.1.2. Live Attenuated Vaccines
9.1.3. Recombinant Vaccines
9.2. Application Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Marek’s Disease
9.2.2. Newcastle Disease
9.2.3. Infectious Bursal Disease
9.2.4. Infectious Bronchitis
9.2.5. Others
9.3. Formulation Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Dry Form (Duct) Vaccines
9.3.2. Liquid Vaccines
9.3.3. Freeze Dried Vaccines
9.4. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2017 – 2023
9.6. North America Poultry Vaccines Market Dynamics – Trends
10. EUROPE POULTRY VACCINES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
10.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.1.1. Germany
10.1.2. UK
10.1.3. France
10.1.4. Spain
10.1.5. Italy
10.1.6. Russia
10.1.7. Poland
10.1.8. Rest of Europe
10.2. Europe Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2017 – 2023
10.3. Europe Poultry Vaccines Market Dynamics – Trends
11. ASIA-PACIFIC POULTRY VACCINES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
11.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.1.1. Japan
11.1.2. China
11.1.3. India
11.1.4. ASEAN
11.1.5. Australia & New Zealand
11.1.6. Rest of Asia-Pacific
11.2. Asia-Pacific Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2017 – 2023
11.3. Asia-Pacific Poultry Vaccines Market Dynamics – Trends
12. LATIN AMERICA POULTRY VACCINES MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
12.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.1.1. Brazil
12.1.2. Mexico
12.1.3. Argentina
12.1.4. Venezuela
12.1.5. Rest of Latin America
12.2. Latin America Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2017 – 2023
12.3. Latin America Poultry Vaccines Market Dynamics – Trends
13. MIDDLE EAST AND AFRICA POULTRY VACCINES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
13.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.1.1. Gulf Cooperation Council (GCC) Countries
13.1.2. Israel
13.1.3. South Africa
13.1.4. Rest of MEA
13.2. MEA Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2017 – 2023
13.3. MEA Poultry Vaccines Market Dynamics – Trends
14. COMPETITION LANDSCAPE
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Zoetis (Pfizer, Inc.) (U.S.)
14.2.2. Merck & Co. Inc. (U.S)
14.2.3. Boehringer Ingelheim Vetmedica (Germany)
14.2.4. Elanco (U.S.)
14.2.5. Bayer Animal Health (Germany)
14.2.6. Ceva Sante Animale (France)
14.2.7. Indovax Pvt. Ltd. (India)
14.2.8. Hester Biosciences Limited. (India)
14.2.9. Zydus AHL (India)
15. RESEARCH METHODOLOGY
16. KEY ASSUMPTIONS AND ACRONYMS
